The clinical trials of a vaccine that he created for the coronavirus and is expected to be released next year started today (22/03) the Thailand. According to the country’s Minister of Health, this preparation can give the Authorities more freedom in terms of its vaccination policy.
As Anutin Tsarnvirakul pointed out, the vaccine will give Thailand more options and fewer restrictions. “But today, if we succeed, we can chart our own course,” he commented.
Thailand aims to vaccinate half of its adult population by the end of the year, using 61 million doses of the AstraZeneca vaccine to be produced in the country from June.
The domestic vaccine is being developed by the state pharmaceutical company Government Pharmaceutical Organization in collaboration with the Department of Tropical Medicine and an American NGO and uses an inactivated virus to induce immunity.
“The vaccine, made by Thais for Thais, is expected to be ready for use from next year“, Said in a press conference Piyasacol Sacolsadayadorn, President of the Council of Mahidol University, as reported by APE-MPE.
Thailand is developing a domestic vaccine against Covid-19, along with other countries such as Japan and Taiwan, amid restrictions on the supply of vaccines worldwide and the emergence of new strains of the virus.
Last week, Vietnam announced that its own coronavirus vaccine would be available by the fourth quarter of the year.
The rector of Mahidol University, Bangzong Mahaisavariya, announced that 460 volunteers had been admitted to take part in the clinical trials, of which 210 would take part in the first phase. The second phase is expected to start in June with the results estimated to be available by the end of the year.
Another home vaccine is being developed by Chulalongkorn University and uses mRNA technology (genetic information to create the coronavirus’ spike protein). And with this vaccine, clinical trials are expected to begin soon.
Thailand has recorded a total of 27,876 cases of coronavirus and 91 deaths.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
